Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Working Concentration: 0.625 µg/mL. Sensitivity: 1 ng/mL LSD produces 82% inhibition in a competitive ELISA employing Lysergic Acid Diethylamide (LSD) polyclonal antibody.
LSD is a semisynthetic derivative of ergot (Claviceps purpurea). Lysergide has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood. [National Center for Biotechnology Information. PubChem Compound Database; CID=5761].
仅用于科研。不用于诊断过程。未经明确授权不得转售。